Abingworth LLP 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-07 4:39 pm Purchase | 2022-03-28 | 13D | Vera Therapeutics, Inc. VERA | Abingworth LLP | 2,970,156 11.100% | 9,925 (+0.34%) | Filing |
| 2021-05-24 09:34 am Purchase | 2021-05-18 | 13D | Vera Therapeutics, Inc. VERA | Abingworth LLP | 2,960,231 14.600% | 2,960,231 (New Position) | Filing |